NCT05271019

Brief Summary

Lung transplantation is an effective therapeutic option in the end-stage of chronic respiratory diseases. Lung transplantation improves lung function in terms of capacity and volume. However, the transplanted patient still suffers from muscle weakness and exercise intolerance. In recent years, respiratory physiotherapy work has intensified in critically ill patients with respiratory muscle weakness and the application of inspiratory muscle training (IMT), which has been shown in several studies to increase inspiratory muscle strength (IMT), improve ventilation and reduce the sensation of shortness of breath. Despite this emerging evidence, inspiratory muscle training (IMT) is not standard practice in most ICUs around the world, nor is it included in a protocolised manner among the components of a pulmonary rehabilitation programme. Given the limited evidence, the investigators propose to conduct this randomised controlled clinical trial in lung transplant recipients. The study will compare two groups of transplanted patients, a control group that will follow the rehabilitation programme and standard medical care and another experimental group that will also perform inspiratory muscle training. This study aims to analyse the effect of IMT on inspiratory muscle strength, exercise capacity and quality of life in lung transplant patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 4, 2022

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

February 16, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 8, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

April 2, 2024

Status Verified

April 1, 2024

Enrollment Period

2.9 years

First QC Date

February 16, 2022

Last Update Submit

April 1, 2024

Conditions

Keywords

respiratory muscle trainingpost lung transplantbreathing exercisesrespiratory exercisespulmonary rehabilitationexercise capacity

Outcome Measures

Primary Outcomes (5)

  • Change in respiratory strength: maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) measured in water centimeters (cmH2O).

    Maximum respiratory pressure will be measure using a Respiratory Pressure Meter (RPM) named Micro-RPM® . Ever since Black and Hyatt (1969) reported this technique, it is used in healthy control subjects across all ages and athletes. Pressure is recorded at the mouth during quasi-static short (few seconds) maximal breathing according to American Thoracic Society (ATS) guidelines.The maximum value will be obtained. Am J respi Crit Care Med 2002;166:531-535.

    The groups will be assessed at six times:Pre -Lung transplantation (Pre-LT), at baseline, every 15 days and 3 months after LT

  • Change in functional capacity: 6 minutes walk test (6MWT) measured in meters

    6MWT is a submaximal exercise test that entails measurement of distance walked during 6 minutes. The 6MWT provides information regarding functional capacity, response to therapy and prognosis. The test will be in line with American Thoracic Society (ATS) guidelines Statement Guidelines for the Six Minutes Walk Test. Am J respi Crit Care Med 2002;166(1):111-117

    The groups will be assessed Pre-LT and 3 months after LT

  • Change in Quality of life related with Health(SF-36) measured with a score from 0 to100

    The SF-36 consists of 36 topics that explore eight dimensions of health status: physical function, physical role, bodily pain, general health, vitality, social function, emotional role, and mental health.The SF-36 was previously validated in chronic obstructive pulmonary disease (COPD) patients and has been used in patients before and after lung transplantation (LT). Respiration 2000;67:159-65. Chest 2000;118:408-16.

    The groups will be assessed Pre-LT and 3 months after LT

  • Change in Respiratory mechanics parameters: respiratory work measured in Joules (J)

    Respiratory mechanics parameters will be analyzed using a POWERbreathe electronic device: the work of breathing is the area for total external inspiratory work as integrated from mouth pressure (cmH2O) and volume (L) signals over time. Physical Therapy 2015;95(9):1264-1273

    The groups will be assessed at baseline, every 15 days and 3 months after LT

  • Change in Inspiratory muscle endurance (Tlim) measure in seconds (s)

    Inspiratory muscle endurance is the time the patient breathe against a submaximal inspiratory load provided by device (POWERbreathe) until task failure due to the symptom limitation. Physical Therapy 2015;95(9):1264-1273.

    The groups will be assessed at baseline, every 15 days and 3 months after LT

Secondary Outcomes (3)

  • Changes in dyspnea measured with the modified borg scale 0-10

    The groups will be assessed at baseline, every 15 days and 3 months after LT

  • Incidence of atelectasis measured with a score from 0 to 4

    The patients will be assessed through study completion, an average of 3 months

  • Change in Pulmonary Function measured with Spirometry Test. FEV1/FVC measured in %

    The groups will be assessed Pre-LT, at baseline and 3 months after LT

Study Arms (2)

Control group: Conventional Rehabilitation Program

NO INTERVENTION

Standard rehabilitation program for 3 months, starting in the early phase in the ICU. A daily session from monday to friday. It includes breathing and secretions management exercises, building upper and lower extremity range of motion. Exercise progression should gradually incorporate aerobic exercises (treadmill, cycloergometer and upper and lower limb strength exercises) and limb strength training. Aerobic exercise at moderate intensity (no more than 3-4/10 on the modified Borg scale). Aerobic exercise starting with 20 minutes and gradually increasing up to 30 minutes. Limb strength training from 1 to 3 sets of 8-10 repetitions at moderate intensity.

Experimental group: Conventional Rehabilitation Program + Inspiratory Muscle Training (IMT)

EXPERIMENTAL

Standard rehabilitation program for 3 months, starting in the early phase in the ICU. A daily session from monday to friday. It includes breathing and secretions management exercises, building upper and lower extremity range of motion. Exercise progression should gradually incorporate aerobic exercises (treadmill, cycloergometer and upper and lower limb strength exercises) and limb strength training. Aerobic exercise at moderate intensity (no more than 3-4/10 on the modified Borg scale). Aerobic exercise starting with 20 minutes and gradually increasing up to 30 minutes. Limb strength training from 1 to 3 sets of 8-10 repetitions at moderate intensity.

Device: Threshold load device

Interventions

Inspiratory Muscle Training (IMT) for 3 months: Though a threshold loading device (5 sets of 6 repetitions, 1session/day, 5 days/week). the inspiratory load will start at 30% of MIP, or up to the maximum patient-tolerable load (max 60% of MIP), no more than 3-5/10 on the modified Borg scale.

Experimental group: Conventional Rehabilitation Program + Inspiratory Muscle Training (IMT)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Alert or able to cooperate with treatment.
  • Able to give Informed Consent and sign it.
  • Haemodynamically stable clinical situation or requiring minimal ventilatory support.

You may not qualify if:

  • Detection of complete paralysis of the diaphragm.
  • Progressive neuromuscular diseases or with spinal cord injury.
  • Lack of collaboration or cooperation, or non-alertness (Glasgow ≤8).
  • Unstable clinical situation (patients requiring high levels of ventilatory support (e.g., Positive End Expiratory Pressure (PEEP)\> 10 cmH2O, Fraction Pressure of Inspired Oxygen (FiO2)\> 0.60, nitric oxide, nebulised prostacyclin, high frequency oscillation).
  • Clinical situation compromising the patient's recovery (cardiac arrhythmias, acute sepsis).
  • When the medical treatment team and/or physiotherapy consider that there may be risks.
  • Severe pain or dyspnoea that interferes with or impedes the ability to breathe (e.g. rib fracture).
  • Patients with lung retransplantation.
  • Heart and lung transplant patients.
  • When the patient is on palliative treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laura Muelas Gómez

Majadahonda, Madrid, 28222, Spain

RECRUITING

Related Publications (10)

  • Pehlivan E, Mutluay F, Balci A, Kilic L. The effects of inspiratory muscle training on exercise capacity, dyspnea and respiratory functions in lung transplantation candidates: a randomized controlled trial. Clin Rehabil. 2018 Oct;32(10):1328-1339. doi: 10.1177/0269215518777560. Epub 2018 May 30.

    PMID: 29843525BACKGROUND
  • Nissan Graur PW and MRK. Annals of Physiotherapy Clinics Effects of Inspiratory Muscle Training on Respiratory Muscle Strength , Functional Capacity and Health Related Quality of Life of Patients Following Lung Transplantation. Ann Physiother Clin. 2020;2(1):10-2.

    BACKGROUND
  • Neumannova K, Kuzilkova V, Zurková M, Hubackova L, Michalcikova T, Jakubec P, et al. Respiratory muscle training improves the work of breathing and decreases inspiratory muscle fatigue in patients after lung transplantation. Eur Respir J. 2019 Sep 28;54(suppl 63)

    BACKGROUND
  • Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011 Feb;37(2):416-25. doi: 10.1183/09031936.00031810.

    PMID: 21282809BACKGROUND
  • Hoffman M, Augusto VM, Eduardo DS, Silveira BMF, Lemos MD, Parreira VF. Inspiratory muscle training reduces dyspnea during activities of daily living and improves inspiratory muscle function and quality of life in patients with advanced lung disease. Physiother Theory Pract. 2021 Aug;37(8):895-905. doi: 10.1080/09593985.2019.1656314. Epub 2019 Aug 20.

    PMID: 31429627BACKGROUND
  • Kendall F, Oliveira J, Peleteiro B, Pinho P, Bastos PT. Inspiratory muscle training is effective to reduce postoperative pulmonary complications and length of hospital stay: a systematic review and meta-analysis. Disabil Rehabil. 2018 Apr;40(8):864-882. doi: 10.1080/09638288.2016.1277396. Epub 2017 Jan 17.

    PMID: 28093920BACKGROUND
  • Langer D, Burtin C, Schepers L, Ivanova A, Verleden G, Decramer M, Troosters T, Gosselink R. Exercise training after lung transplantation improves participation in daily activity: a randomized controlled trial. Am J Transplant. 2012 Jun;12(6):1584-92. doi: 10.1111/j.1600-6143.2012.04000.x. Epub 2012 Mar 5.

    PMID: 22390625BACKGROUND
  • Candemir I, Ergun P, Kaymaz D, Demir N, Tasdemir F, Sengul F, Egesel N, Yekeler E. The Efficacy of Outpatient Pulmonary Rehabilitation After Bilateral Lung Transplantation. J Cardiopulm Rehabil Prev. 2019 Jul;39(4):E7-E12. doi: 10.1097/HCR.0000000000000391.

    PMID: 31241521BACKGROUND
  • Yamaga T, Yamamoto S, Sakai Y, Ichiyama T. Effects of inspiratory muscle training after lung transplantation in children. BMJ Case Rep. 2021 Jul 21;14(7):e241114. doi: 10.1136/bcr-2020-241114.

    PMID: 34290002BACKGROUND
  • Langer D, Gosselink R, Pitta F, Burtin C, Verleden G, Dupont L, Decramer M, Troosters T. Physical activity in daily life 1 year after lung transplantation. J Heart Lung Transplant. 2009 Jun;28(6):572-8. doi: 10.1016/j.healun.2009.03.007. Epub 2009 May 5.

    PMID: 19481017BACKGROUND

MeSH Terms

Conditions

Muscle WeaknessRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsRespiration DisordersRespiratory Tract Diseases

Study Officials

  • Laura Muelas Gómez, PT, MSc

    Hospital Universitario Puerta de Hierro Majadahonda

    PRINCIPAL INVESTIGATOR
  • Maria de los Angeles Atín Arratibel, MD, PhD

    Universidad Complutense de Madrid

    STUDY DIRECTOR
  • Maria A Cebria i Iranzo, PT, PhD

    Hospital Universitario y Politécnico La Fe,Valencia

    STUDY DIRECTOR
  • Ignacio Latorre-Marco, DUE

    Hospital Universitario Puerta de Hierro Majadahonda

    STUDY CHAIR
  • Montserrat Solis Muñoz, DUE, PhD

    Hospital Universitario Puerta de Hierro Majadahonda

    STUDY CHAIR
  • Ana Royuela Vicente, Phd

    Hospital Universitario Puerta de Hierro Majadahonda

    STUDY CHAIR
  • Cristina Ruiz González, PT

    Hospital Universitario Puerta de Hierro Majadahonda

    STUDY CHAIR
  • Silvia Herguedas Cristobal, PT

    Hospital Universitario Puerta de Hierro Majadahonda

    STUDY CHAIR
  • Sofia González López, MD

    Hospital Universitario Puerta de Hierro Majadahonda

    STUDY CHAIR

Central Study Contacts

Laura Muelas Gómez, PT, MSc

CONTACT

Montserrat Solis Muñoz, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Neither the professionals in charge of measuring the pre- and post-intervention outcomes nor the statistician are aware of the assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical physiotherapist

Study Record Dates

First Submitted

February 16, 2022

First Posted

March 8, 2022

Study Start

February 4, 2022

Primary Completion

December 15, 2024

Study Completion

April 30, 2025

Last Updated

April 2, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

For now I don't want to share information about the study until I have the protocol or some published results of the intervention. At that time, the information will be shared with the other researchers.

Locations